Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Original Products Holding Their Own in Competition with Generics
February 12, 2007
- R&D NEWS IN BRIEF
February 12, 2007
- Molecular Imaging Research Symposium 2007
February 12, 2007
- Takeda to Build New Research Center in Fujisawa
February 12, 2007
- REGULATORY NEWS IN BRIEF
February 12, 2007
- Trial Fails to Show Non-Inferiority of Iressa to Docetaxel
February 12, 2007
- 7 Drugs/5 APIs Recommended for Approval
February 12, 2007
- Sysmex Launches New Automated Hematology Analyzer in Europe
February 12, 2007
- Dialogue to Be Held Once or Twice a Year: EAD Director
February 12, 2007
- ON THE MOVE
February 12, 2007
- 1st Gov't-Private Sector Dialogue Held
February 12, 2007
- BUSINESS NEWS IN BRIEF
February 12, 2007
- NEW PRODUCTS
February 12, 2007
- AstraZeneca to Cut 3,000 Jobs Worldwide
February 12, 2007
- Tanabe Seiyaku, Mitsubishi Pharma Corporation to Merge Oct. 1
February 12, 2007
- GENERIC NEWS IN BRIEF
February 5, 2007
- Sale of Alimta to Be Limited to 400 Facilities for Now: Eli Lilly Japan
February 5, 2007
- Use of Generics Being Promotedby Spread of DPC System: Dr Chikamori
February 5, 2007
- METI to Solve Problems with Transfer Pricing Taxation System
February 5, 2007
- R&S NEWS IN BRIEF
February 5, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…